BIM Share Price

Open 147.25 Change Price %
High 149.25 1 Day 0.50 0.34
Low 145.60 1 Week 2.75 1.89
Close 148.30 1 Month -2.05 -1.36
Volume 21322 1 Year 47.95 47.78
52 Week High 153.25
52 Week Low 98.40
BIM Important Levels
Resistance 2 151.68
Resistance 1 150.29
Pivot 147.72
Support 1 146.31
Support 2 144.92
EPA France Most Active Stocks
MT 4.53 12.97%
MT 4.53 12.97%
MT 4.53 12.97%
MT 4.53 12.97%
MT 4.53 12.97%
GSZ 17.56 3.97%
GSZ 17.56 3.97%
GSZ 17.56 3.97%
AVQ 0.33 -5.71%
BRS 12.00 0.00%
More..
EPA France Top Gainers Stocks
MLGEO 0.06 20.00%
APAM 33.78 15.72%
APAM 33.78 15.72%
MLLOI 3.80 15.15%
DEXB 17.47 13.89%
DEXB 17.47 13.89%
ALDIE 1.40 13.82%
MT 4.53 12.97%
MT 4.53 12.97%
MT 4.53 12.97%
More..
EPA France Top Losers Stocks
MLPGO 0.11 -21.43%
MLHOT 27.00 -8.47%
ALEUP 0.35 -7.89%
FCMC 1305.00 -7.32%
AVQ 0.33 -5.71%
FPG 0.72 -5.26%
FPG 0.72 -5.26%
XIL 15.26 -4.62%
BCAM 115.00 -4.17%
GBB 9.99 -3.94%
More..

BioMerieux SA (EPA: BIM)

BIM Technical Analysis 4
As on 22nd Mar 2017 BIM Share Price closed @ 148.30 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 132.26 & Buy for SHORT-TERM with Stoploss of 147.51 we also expect STOCK to react on Following IMPORTANT LEVELS.
BIM Target for March
1st Target up-side 149.46
2nd Target up-side 152.47
3rd Target up-side 155.49
1st Target down-side 140.84
2nd Target down-side 137.83
3rd Target down-side 134.81
BIM Other Details
Segment EQ
Market Capital 0.00
Sector Healthcare
Industry Medical Laboratories & Research
Offical website http://www.biomerieux.com
BIM Address
BIM
376, chemin de l
Marcy l'Etoile, 69280
France
Phone: 33 4 78 87 20 00
Fax: 33 4 78 87 20 90
BIM Latest News
Interactive Technical Analysis Chart BioMerieux SA ( BIM EPA France )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on BioMerieux SA
BIM Business Profile
bioMérieux SA designs, develops, manufactures, and markets in vitro diagnostic systems for clinical and industrial applications. The company’s diagnostic systems consist of reagents and consumables used to conduct biological tests, for use in performing screening, diagnostic assistance, prognosis, and treatment monitoring; instruments, platforms, or autoanalyzers used for automated testing at high or low throughputs; software to process analyses and systems to interpret the biological test results; and related services, such as the installation and maintenance of instruments, user training, or the audit of laboratory workflows. It offers diagnostic systems for clinical applications, including the diagnosis of infectious diseases, comprising HIV, tuberculosis, and respiratory diseases, as well as cardiovascular diseases and targeted cancers based on the analysis of biological samples, such as blood, saliva, and urine; and for industrial applications, including the analysis of microbiological manufacturing, such as food, pharmaceuticals, and cosmetics. The company markets and sells its products through a network of distributors to private-sector analysis laboratories, hospital laboratories, blood banks, and physician office laboratories; food, pharmaceutical, and cosmetics industries; and independent quality-control laboratories. It has operations in Europe, the Middle East, Africa, North America, Asia-Pacific, and Latin America. The company was formerly known as B-D Mérieux and changed its name to bioMérieux SA. The company was founded in 1963 and is headquartered in Marcy l’Etoile, France. bioMérieux SA is a subsidiary of Institut Mérieux.